The invasive GBM cells in the resection margin or within 2 cm of the resection cavity shows a decrease in their rate of proliferation and a relative resistance to apoptosis, thus higher expression levels of IRF9 and XRCC1 in PsP group may contribute to the non-recurrence of GBM. The gene discussed is IRF9; the disease is glioblastoma.